Please login to the form below

Nichi-Iko

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nichi-Iko's Japan sales performance.

Roche’s Tamiflu successor hits the mark in complicated flu

Also in its favour is that baloxavir marboxil is already on the market in Japan, where its originator Shionogi won approval earlier this year as Xofluza.

The NHS at 70th: celebrations, renewed reforms and difficult choices

This still leaves it in line with an unweighted EU-15 average of 9.8% of national income, but far behind countries such as the US (16.9%), Japan (11.2%),

Daily Brief: DDF hits £250m investment, Hard Brexit could cost UK £100bn in trade and troublesome results for Pfizer’s Ibrance

Business reps from the US, Canada, Japan and India issued a joint statement this week, which said that international businesses who are “heavily invested”in both the EU and the UK ... Canada Europe Roundtable for Business, the Europe India Chamber of

The year of the blockbuster

The therapy was filed in Japan in March and an EU filing (February) is also pending. ... just as the Drugs to Watch report was released; EU and Japan approvals also occurred that month.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Client Services Director - Med Comms: Great salary and bebefits

Senior Account Manager: Competitive salary commensurate with experience

Home based, Principal Medical Writer, Medical Communications: Excellent package

Account Manager: £40, 000 - £45, 000 benefits

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Editorial Director – Medical Education (MedComms): Neg

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Client Services Director – Healthcare Advertising - London: Neg

Home based, Chief Medical Writer, Medical Communications: Excellent package

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Home based, Editorial Team Leader, Medical Communications: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Delivery Manager/ Head of Delivery – Executive Search: Neg

Home based, Senior Medical Writer, Medical Communications: Excellent package

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Senior Project Manager - Medical Writing: Great salary and bebefits

Business Unit Head, Medical Communications, London: Excellent package

Healthcare PR Director: £100, 000 – £120, 000 benefits

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....